It has been reported that LUCAT1 has an antitumour effect by modulating miRNA expression and signalling pathways in clear cell renal cell carcinoma, bladder cancer, colorectal cancer, hepatocellular carcinoma, breast cancer and cervical cancer 27. Here, LUCAT1 is linked to cervical carcinoma.